UK healthcare technology companies urged to tap into growing Middle East markets

23 January 2009

UK Trade & Investment (UKTI) and the Association of British Healthcare Industries (ABHI) are urging UK healthcare technology businesses to capitalise on demand in the fast growing Middle East market, which is expected to be worth $60bn by 2025.

A combination of a growing population and improving standards of living are creating heightened expectations of the standard of care. This in turn is driving investment in hospitals and medical facilities, and pushing up demand for state-of–the art drugs and therapies.

To help British companies to tap into these opportunities, UKTI and the ABHI are supporting more than 120 British companies, which will be showcasing innovative products at Arab Health from January 26-29th this year. In addition to funding through UKTI’s Trade Show Access Programme (TAP), these companies will have the opportunity to meet more than 15 buyers from around the Middle East.

Businesses on the UK pavilion will be offering Middle East healthcare providers the opportunity to view the latest, cutting-edge medical equipment, which can help to foster excellence in the Gulf’s fast-developing healthcare systems.

Sir Andrew Cahn, Chief Executive of UK Trade & Investment, said: “With a fast growing population and rapid investment into healthcare services, the Middle East needs access to innovative medical technologies which will support the development of world-class healthcare systems. The UK’s deep heritage of scientific excellence, innovation, talent and skills mean that British companies are well placed to meet this demand.

“Arab Health is a fantastic opportunity for the UK to showcase some of the most exciting developments in healthcare. With the backing of UK Trade & Investment and ABHI I believe businesses attending this year’s event will be able to forge strong and productive relationships with organisations in the Middle East market.”

ABHI’s Chief Executive, Peter Ellingworth, said: “ABHI is taking a record number of UK companies to Arab Health in January 2009 proving the growing importance of this key exhibition. The UK is greatly respected for its quality and innovation around the world, especially in the Middle East. With a strong, well-branded UK pavilion, supporting seminars and receptions, many UK companies are achieving great success and gaining lucrative business from this key event. Arab Health remains, without doubt, the leading healthcare tradeshow for the Middle East, and one that increasingly cannot be missed.”

With a highly skilled manufacturing base, together with outstanding research and development facilities, UK companies are at the forefront of providing innovative products and services for hospitals, doctors’ surgeries, laboratories and diagnostics, and for home care. Companies range from those providing bougies and tuning forks through to advanced electrotherapy products and other medical, scientific and industrial products and services.

Some of the innovative UK companies attending Arab Health include: Summit Medical Ltd. manufactures single-use medical devices for hospitals in the UK, and for export around the world. Its main products include HiVac, a bone cement used by orthopaedists in joint replacement surgery, and CellTrans, a system which collects and reinfuses shed blood following hip or knee surgery.

With the support of UKTI, Summit Medical has just despatched its first order, worth in excess of US$20,000, to the Middle East, for orthopaedic bone cement mixing systems. The innovative product, which is used by surgeons in theatre, is destined for the University Hospital in Dammam. Summit Medical operates in Saudi Arabia through an exclusive distributor, Al Mofadaly Est, which has offices in Riyadh, Jeddah and Dammam.

An excellent example of eldercare products is the new addition to Malem Medical’s product range, which takes the form of a pressure / de-pressure (ie sit-down / getting up) mat that can be attached to any Malem Medical alarm. This is of particular interest to nursing homes and the geriatric population generally, as well as patients suffering from Alzheimers. It allows carers to know if the person under supervision is getting up or moving into dangerous areas, for example with steps or stairs. Malem’s products are in line with the UK’s emphasis on encouraging treatment at one’s own home, either by oneself or by one’s carer.

Oxfordshire-based Owen Mumford is a specialist manufacturer of small medical devices including innovative blood sampling products for home, as well as clinical use. Its advanced automatic injection devices and pen needles are designed for maximum comfort. They are designed to help patients to self-manage conditions such as diabetes at home, as well as facilitating diagnosis and treatment in hospitals and GP surgeries by healthcare professionals.

Products being exhibited in the diagnostic sphere include Kimal’s Angioflow diagnostic catheters and Maltron’s pioneering Electrical Impedance tomography imaging system, which, used bed-side in the assessment of lung disease, is the world’s first non-invasive product of its type.

Another Oxfordshire-based company, Penlon, will be launching its latest Anasthesia Ventilator at Arab Health. This hosts a number of exciting new features including electronic PEEP in all modes, a large 12.1" colour display, and an integrated electronic flow meter for the anaesthesia system, plus sophisticated advanced patient support modes.

Bookmark this page

Your browser does not support inline frames or is currently configured not to display inline frames.	Your browser does not support inline frames or is currently configured not to display inline frames. UK healthcare technology companies urged to tap into growing Middle East markets 23 January 2009 UK Trade & Investment (UKTI) and the Association of British Healthcare Industries (ABHI) are urging UK healthcare technology businesses to capitalise on demand in the fast growing Middle East market, which is expected to be worth $60bn by 2025. A combination of a growing population and improving standards of living are creating heightened expectations of the standard of care. This in turn is driving investment in hospitals and medical facilities, and pushing up demand for state-of–the art drugs and therapies. To help British companies to tap into these opportunities, UKTI and the ABHI are supporting more than 120 British companies, which will be showcasing innovative products at Arab Health from January 26-29th this year. In addition to funding through UKTI’s Trade Show Access Programme (TAP), these companies will have the opportunity to meet more than 15 buyers from around the Middle East. Businesses on the UK pavilion will be offering Middle East healthcare providers the opportunity to view the latest, cutting-edge medical equipment, which can help to foster excellence in the Gulf’s fast-developing healthcare systems. Sir Andrew Cahn, Chief Executive of UK Trade & Investment, said: “With a fast growing population and rapid investment into healthcare services, the Middle East needs access to innovative medical technologies which will support the development of world-class healthcare systems. The UK’s deep heritage of scientific excellence, innovation, talent and skills mean that British companies are well placed to meet this demand. “Arab Health is a fantastic opportunity for the UK to showcase some of the most exciting developments in healthcare. With the backing of UK Trade & Investment and ABHI I believe businesses attending this year’s event will be able to forge strong and productive relationships with organisations in the Middle East market.” ABHI’s Chief Executive, Peter Ellingworth, said: “ABHI is taking a record number of UK companies to Arab Health in January 2009 proving the growing importance of this key exhibition. The UK is greatly respected for its quality and innovation around the world, especially in the Middle East. With a strong, well-branded UK pavilion, supporting seminars and receptions, many UK companies are achieving great success and gaining lucrative business from this key event. Arab Health remains, without doubt, the leading healthcare tradeshow for the Middle East, and one that increasingly cannot be missed.” With a highly skilled manufacturing base, together with outstanding research and development facilities, UK companies are at the forefront of providing innovative products and services for hospitals, doctors’ surgeries, laboratories and diagnostics, and for home care. Companies range from those providing bougies and tuning forks through to advanced electrotherapy products and other medical, scientific and industrial products and services. Some of the innovative UK companies attending Arab Health include: Summit Medical Ltd. manufactures single-use medical devices for hospitals in the UK, and for export around the world. Its main products include HiVac, a bone cement used by orthopaedists in joint replacement surgery, and CellTrans, a system which collects and reinfuses shed blood following hip or knee surgery. With the support of UKTI, Summit Medical has just despatched its first order, worth in excess of US$20,000, to the Middle East, for orthopaedic bone cement mixing systems. The innovative product, which is used by surgeons in theatre, is destined for the University Hospital in Dammam. Summit Medical operates in Saudi Arabia through an exclusive distributor, Al Mofadaly Est, which has offices in Riyadh, Jeddah and Dammam. An excellent example of eldercare products is the new addition to Malem Medical’s product range, which takes the form of a pressure / de-pressure (ie sit-down / getting up) mat that can be attached to any Malem Medical alarm. This is of particular interest to nursing homes and the geriatric population generally, as well as patients suffering from Alzheimers. It allows carers to know if the person under supervision is getting up or moving into dangerous areas, for example with steps or stairs. Malem’s products are in line with the UK’s emphasis on encouraging treatment at one’s own home, either by oneself or by one’s carer. Oxfordshire-based Owen Mumford is a specialist manufacturer of small medical devices including innovative blood sampling products for home, as well as clinical use. Its advanced automatic injection devices and pen needles are designed for maximum comfort. They are designed to help patients to self-manage conditions such as diabetes at home, as well as facilitating diagnosis and treatment in hospitals and GP surgeries by healthcare professionals. Products being exhibited in the diagnostic sphere include Kimal’s Angioflow diagnostic catheters and Maltron’s pioneering Electrical Impedance tomography imaging system, which, used bed-side in the assessment of lung disease, is the world’s first non-invasive product of its type. Another Oxfordshire-based company, Penlon, will be launching its latest Anasthesia Ventilator at Arab Health. This hosts a number of exciting new features including electronic PEEP in all modes, a large 12.1" colour display, and an integrated electronic flow meter for the anaesthesia system, plus sophisticated advanced patient support modes. Bookmark this page Your browser does not support inline frames or is currently configured not to display inline frames. To top	Your browser does not support inline frames or is currently configured not to display inline frames.